RPS6KB1 and breast cancer: Amplification of S6K1 (p70S6K1, ribosomal protein S6KB1) and elevated levels of phosphorylated S6K1 are considered biomarkers of aggressive breast cancer (BCa) that are resistant to neoadjuvant chemotherapy (Kim EK.